Vascular Age: A narrative review of assessment methods, clinical applications, and future directions

Zisu Yang1, Xiaobo Wang2, Lihua Li1,3

  • 1Department of Gerontology, The First Affiliated Hospital of Dali University, Jiashibo Road 32, Dali, 671000, Yunnan Province, China.

Insights

Vascular age (VA) offers a better measure of cardiovascular health than chronological age, improving risk assessment and patient communication. This review explores VA assessment methods and their clinical applications for cardiovascular disease prevention.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Traditional CVD risk models struggle with intermediate-risk stratification.
  • Vascular age (VA) provides a biological measure of vascular health, potentially improving risk assessment and patient engagement.

Purpose of the Study:

  • To review current methods for assessing vascular age (VA).
  • To discuss clinical advances and applications of VA in cardiovascular disease (CVD) risk stratification.
  • To explore emerging technologies and future directions for VA implementation.

Main Methods:

  • Systematic review of literature on VA assessment.
  • Analysis of techniques including arterial stiffness (e.g., pulse wave velocity), vascular structure (e.g., carotid intima-media thickness, coronary artery calcium score), and vascular function.
  • Inclusion of emerging AI-based methods (e.g., deep learning from photoplethysmography, retinal images).

Main Results:

  • VA integrates multiple risk factors and cumulative vascular damage.
  • VA aids in stratifying intermediate-risk individuals and enhancing physician-patient communication.
  • Applications include personalized treatment guidance and use in specific populations (diabetes, rheumatoid arthritis).

Conclusions:

  • Vascular age represents a promising tool for enhancing cardiovascular disease risk assessment and management.
  • Standardization of methods, reference values, and cost-effectiveness studies are needed for widespread clinical adoption.
  • Future research should focus on technological innovation and clinical trial validation for practical VA implementation.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
514
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
976
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
973